IL2R monoclonal antibody/Tacrolimus/MMF

daclizumab or basiliximab with tacrolimus and mycophenolate mofetil

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IL2R monoclonal antibody/Tacrolimus/MMF, covering 2021-09-29 to 2021-09-29. Get the full timeline:

Most recent: Clinical Trial Update: CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation [Phase 4]